SIEN · Sientra, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Revenue | $90.55M | $80.68M | $71.24M | $83.70M | $20.73M | $20.73M |
| Cost of Revenue | $48.95M | $36.35M | $32.30M | $33.01M | $6.88M | - |
| Gross Profit | $41.59M | $44.34M | $38.94M | $50.69M | $41.30M | $22.37M |
| R&D | $14.06M | $10.46M | $10.31M | $13.54M | $10.95M | $9.81M |
| SG&A | $41.53M | $31.77M | $38.19M | $46.77M | $42.42M | $31.54M |
| Total Operating Expenses | $110.64M | $90.69M | $109.25M | $154.25M | $121.08M | $85.26M |
| D&A | $6.64M | $4.36M | $4.09M | $3.52M | $3.32M | $3.03M |
| Operating Income | ($69.05M) | ($46.35M) | ($70.31M) | ($103.57M) | ($79.77M) | ($62.89M) |
| Interest Expense | $9.11M | $8.25M | $9.45M | $4.57M | $3.43M | $1.23M |
| Income Tax | $27.0K | $21.0K | $33.0K | $34.0K | ($4.0K) | $0 |
| Net Income | ($73.31M) | ($62.48M) | ($89.95M) | ($106.82M) | ($82.63M) | ($64.03M) |
| EPS - Basic | ($17.91) | - | - | - | - | - |
| EPS - Diluted | ($17.91) | - | - | - | - | - |
Balance Sheet
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $26.07M | $51.77M | $54.97M | $87.61M | $86.90M | $26.59M |
| Accounts Receivable | $36.89M | $33.10M | $23.50M | $27.55M | $22.53M | $6.57M |
| Inventory | $42.69M | $52.91M | $48.65M | $39.61M | $24.09M | $20.90M |
| Accounts Payable | $6.82M | $7.40M | $6.50M | $9.35M | $13.18M | $5.81M |
| Current Assets | $107.75M | $140.77M | $129.27M | $157.26M | $136.12M | $55.56M |
| Total Assets | $165.42M | $199.90M | $168.98M | $204.40M | $168.36M | $92.21M |
| Current Liabilities | $90.35M | $80.02M | $70.66M | $70.47M | $64.14M | $50.35M |
| Long-term Debt | $55.41M | $62.43M | $60.50M | $38.25M | $27.88M | - |
| Total Liabilities | $165.83M | $159.05M | $169.53M | $122.52M | $101.48M | $64.59M |
| Stockholders' Equity | ($409.0K) | $40.86M | ($557.0K) | $81.88M | $66.88M | $27.62M |
| Retained Earnings | ($694.65M) | ($621.34M) | ($558.86M) | ($468.92M) | ($362.10M) | ($279.47M) |
Cash Flow
| Line item | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | ($34.87M) | ($42.50M) | ($60.13M) | ($87.03M) | ($34.43M) | ($45.92M) |
| Investing Cash Flow | ($3.59M) | $3.33M | ($4.04M) | ($22.01M) | ($12.84M) | ($20.32M) |
| Financing Cash Flow | $12.76M | $35.94M | $31.52M | $109.76M | $1.68M | $25.61M |
| CapEx | $3.59M | $3.81M | $4.04M | $4.07M | $855.0K | $1.86M |
| Free Cash Flow | ($38.47M) | ($46.30M) | ($64.16M) | ($91.10M) | ($35.28M) | ($47.78M) |
Ratios
| Metric | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 45.9% | 54.9% | 54.7% | 60.6% | 199.2% | 107.9% |
| Operating margin | -76.3% | -57.4% | -98.7% | -123.7% | -384.7% | -303.3% |
| EBITDA margin | -68.9% | -52.0% | -92.9% | -119.5% | -368.7% | -288.7% |
| Net margin | -81.0% | -77.4% | -126.3% | -127.6% | -398.5% | -308.8% |
| Free cash flow margin | -42.5% | -57.4% | -90.1% | -108.8% | -170.2% | -230.4% |
| FCF / Net income | 0.52 | 0.74 | 0.71 | 0.85 | 0.43 | 0.75 |
| R&D / Revenue | 15.5% | 13.0% | 14.5% | 16.2% | 52.8% | 47.3% |
| SG&A / Revenue | 45.9% | 39.4% | 53.6% | 55.9% | 204.6% | 152.1% |
| Effective tax rate | - | - | - | - | - | - |
| Return on assets | -44.3% | -31.3% | -53.2% | -52.3% | -49.1% | -69.4% |
| Return on equity | 17923.5% | -152.9% | 16148.5% | -130.5% | -123.5% | -231.8% |
| Return on invested capital | -99.2% | -35.4% | -92.7% | -68.1% | -66.5% | - |
| Liquidity | ||||||
| Current ratio | 1.19 | 1.76 | 1.83 | 2.23 | 2.12 | 1.10 |
| Quick ratio | 0.72 | 1.10 | 1.14 | 1.67 | 1.75 | 0.69 |
| Cash ratio | 0.29 | 0.65 | 0.78 | 1.24 | 1.35 | 0.53 |
| Leverage | ||||||
| Debt / Equity | -135.47 | 1.53 | -108.62 | 0.47 | 0.42 | - |
| Debt / Assets | 0.33 | 0.31 | 0.36 | 0.19 | 0.17 | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | -7.6x | -5.6x | -7.4x | -22.7x | -23.3x | -51.0x |
| Equity multiplier | -404.45 | 4.89 | -303.37 | 2.50 | 2.52 | 3.34 |
| Liabilities / Assets | 1.00 | 0.80 | 1.00 | 0.60 | 0.60 | 0.70 |
| Efficiency | ||||||
| Asset turnover | 0.55 | 0.40 | 0.42 | 0.41 | 0.12 | 0.22 |
| Inventory turnover | 1.15 | 0.69 | 0.66 | 0.83 | 0.29 | - |
| Days sales outstanding | 149d | 150d | 120d | 120d | 397d | 116d |
| Days inventory outstanding | 318d | 531d | 550d | 438d | 1278d | - |
| Days payable outstanding | 51d | 74d | 73d | 103d | 699d | - |
| Cash conversion cycle | 416d | 607d | 597d | 455d | 975d | - |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 12.2% | 13.3% | -14.9% | 303.7% | 0.0% | - |
| Revenue CAGR (3y) | 2.7% | 57.3% | 50.9% | - | - | - |
| Revenue CAGR (5y) | 34.3% | - | - | - | - | - |
| Gross profit growth (YoY) | -6.2% | 13.9% | -23.2% | 22.7% | 84.6% | 61.5% |
| Operating income growth (YoY) | -49.0% | 34.1% | 32.1% | -29.8% | -26.8% | -57.1% |
| Net income growth (YoY) | -17.3% | 30.5% | 15.8% | -29.3% | -29.0% | -59.4% |
| EPS growth (YoY) | - | - | - | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | 16.9% | 27.8% | 29.6% | -158.2% | 26.2% | -34.4% |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | - | - | - | 22.4% | 142.1% | -67.0% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Geographic
$80.68M totalNorth America$79.04M · 98.0%
Non Us$1.65M · 2.0%
Stability scores
Altman Z′
FY 2022 · bankruptcy risk
-4.23
Distress
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2022 · 9-point quality
3/9
Weak
- ✗Net income positive
- ✗Operating cash flow positive
- ✗ROA improved YoY
- ✓Cash flow > net income
- ✓Long-term debt decreased
- ✗Current ratio improved
- -No share dilution
- ✗Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Orthopedic, Prosthetic & Surgical Appliances & Supplies
Comparing Sientra against the 5 most active filers in the same SIC group.